$1.42
-0.02 (-1.39%)
Open$1.44
Previous Close$1.44
Day High$1.46
Day Low$1.41
52W High$2.89
52W Low$1.15
Volume—
Avg Volume2.94M
Market Cap369.63M
P/E Ratio—
EPS$-0.04
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,037.3% upside
Current
$1.42
$1.42
Target
$16.15
$16.15
$10.52
$16.15 avg
$19.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 954.65M | 868.34M | 59.12M |
| Net Income | -15,904,329 | -13,019,734 | 16.50M |
| Profit Margin | -1.7% | -1.6% | 27.9% |
| EBITDA | 44.33M | 38.31M | 25.74M |
| Free Cash Flow | — | — | 14.78M |
| Rev Growth | +9.9% | +9.9% | +13.8% |
| Debt/Equity | 0.15 | 0.15 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |